ZZPZH(SH:600436) Zheng Quan Shi Bao Wang·2025-09-10 05:50Group 1 - The core viewpoint of the news is that the "2025 New Quality Productivity Investment Institution Soft Power Ranking" was released, with Pizhou Pharmaceutical (600436) being recognized as the only listed company in the traditional Chinese medicine industry to win the "Top 30 Industrial LP" honor [1][2] - The ranking evaluates investment institutions based on six dimensions: value creation, service empowerment, organizational governance, market influence, innovation-driven, and social responsibility, using both quantitative and qualitative analysis [1] - The Chinese private equity investment industry is undergoing a paradigm shift, necessitating investment institutions to explore new development paradigms and better understand new quality productivity [1] Group 2 - The award signifies Pizhou Pharmaceutical's successful transition from traditional pharmaceutical manufacturing to a dual-driven model of "industry + capital," gaining market recognition for its achievements [2] - As a time-honored Chinese medicine enterprise, Pizhou Pharmaceutical has actively accelerated its investment in the industry by establishing multiple industrial funds and identifying potential acquisition targets, effectively integrating upstream and downstream resources [2]